<b>2. Clinical Pharmacokinetics: Application to Bed Side through Extensive Understanding of the Whole Pharmacokinetic Processes in Human Body; Focus on the Renal Drug Excretion</b>-Reference-Cited by-同舟云学术

2. Clinical Pharmacokinetics: Application to Bed Side through Extensive Understanding of the Whole Pharmacokinetic Processes in Human Body; Focus on the Renal Drug Excretion

Published:2016 Issue:2 Volume:47 Page:56-61
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Jpn. J. Clin. Pharmacol. Ther.

Author:

IEIRI Ichiro¹

Affiliation:

1. Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical),Pharmacology

Link

https://www.jstage.jst.go.jp/article/jscpt/47/2/47_56/_pdf

Reference7 articles.

1. 1) Herrera J, Vukovich RA, Griffith DL. Elimination of nadolol by patients with renal impairment. Br J Clin Pharmacol. 1979; 7 Suppl 2: 227S-231S.

2. 2) Nakata J, Ohsawa I, Onda K, Tanimoto M, Kusaba G, Takeda Y, et al. Risk of overestimation of kidney function using GFR-estimating equations in patients with low inulin clearance. J Clin Lab Anal. 2012; 26(4): 248-53. doi: 10.1002/jcla.21513.

3. 3) Andreev E, Koopman M, Arisz L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med. 1999; 246(3): 247-52.

4. 4) Lepist EI, Ray AS. Renal drug-drug interactions: what we have learned and where we are going. Expert Opin Drug Metab Toxicol. 2012; 8(4): 433-48. doi: 10.1517/17425255.2012.667401.

5. 5) Liu R, Tang AM, Tan YL, Limenta LM, Lee EJ. Effects of sodium bicarbonate and ammonium chloride pre-treatments on PEPT2 (SLC15A2) mediated renal clearance of cephalexin in healthy subjects. Drug Metab Pharmacokinet. 2011; 26(1): 87-93.